Fluorescence guided surgery for pituitary adenomas
- 21 February 2021
- journal article
- review article
- Published by Springer Science and Business Media LLC in Journal of Neuro-Oncology
- Vol. 151 (3), 403-413
- https://doi.org/10.1007/s11060-020-03420-z
Abstract
Purpose Resection of pituitary adenomas presents a number of unique challenges in neuro-oncology. The proximity of these lesions to key vascular and endocrine structures as well as the need to interpret neuronavigation in the context of shifting tumor position increases the complexity of the operation. More recently, substantial advances in fluorescence-guided surgery have been demonstrated to facilitate the identification of numerous tumor types and result in increased rates of complete resection and overall survival. Methods A review of the literature was performed, and data regarding the mechanism of the fluorescence agents, their administration, and intraoperative tumor visualization were extracted. Both in vitro and in vivo studies were assessed. The application of these agents to pituitary tumors, their advantages and limitations, as well as future directions are presented here. Results Numerous laboratory and clinical studies have described the use of 5-ALA, fluorescein, indocyanine green, and OTL38 in pituitary lesions. All of these drugs have been demonstrated to accumulate in tumor cells. Several studies have reported the successful use of the majority of the agents in inducing intraoperative tumor fluorescence. However, their sensitivity and specificity varies across the literature and between functioning and non-functioning adenomas. Conclusions At present, numerous studies have shown the feasibility and safety of these agents for pituitary adenomas. However, further research is needed to assess the applicability of fluorescence-guided surgery across different tumor subtypes as well as explore the relationship between their use and postoperative clinical outcomes.Keywords
This publication has 58 references indexed in Scilit:
- Indocyanine green fluorescence endoscopy for visual differentiation of pituitary tumor from surrounding structuresJournal of Neurosurgery, 2012
- Quantitative fluorescence in intracranial tumor: implications for ALA-induced PpIX as an intraoperative biomarkerJournal of Neurosurgery, 2011
- Clival Invasion on Multi-Detector CT in 390 Pituitary Macroadenomas: Correlation with Sex, Subtype and Rates of Operative Complication and RecurrenceAmerican Journal of Neuroradiology, 2011
- The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effectAdvanced Drug Delivery Reviews, 2011
- Exploratory Study of 99mTc-EC20 Imaging for Identifying Patients with Folate Receptor–Positive Solid TumorsJournal of Nuclear Medicine, 2008
- Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trialThe Lancet Oncology, 2006
- The prevalence of pituitary adenomasCancer, 2004
- Endoscopic transsphenoidal pituitary surgery: various surgical techniques and recommended steps for procedural transitionBritish Journal of Neurosurgery, 2000
- Endoscopic endonasal transsphenoidal surgery: experience with 50 patientsJournal of Neurosurgery, 1997
- MR imaging of cavernous sinus involvement by pituitary adenomasAmerican Journal of Roentgenology, 1988